Loading quotes...
Forecast
There is no analyst data available for this company.
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
Nolato misses Q1 forecasts – shares fall 17%
Nolato reported Q1 2026 EPS of $0.67 and revenue of $2.36 billion, missing analyst estimates and leading to a 17.04% share decline to $49.46. Strong organic growth was seen in the Medical Solutions and Engineered Solutions segments, while currency effects and operational issues weighed on operating income and EPS. The company maintained its EBITDA margin at 11%, significantly increased operating cash flow and is pushing strategic expansions, for example in Hungary. » More on de.investing.com
Nolato misses Q1 forecasts – shares fall 17.7% after results
Nolato reported Q1 2026 EPS of $0.67 (expectation $0.712) and revenue of $2.36bn (expectation $2.37bn), after which the stock dropped sharply. Despite the missed numbers, the EBITDA margin held at 11% and operating cash flow rose by 67%. The company cites currency headwinds and rising raw material costs as risks, but maintains its 2026 investment forecast of SEK 650–700m to expand in Hungary and Malaysia. » More on de.investing.com
Nolato misses Q1 forecasts – shares fall around 16%
Nolato reports Q1 2026 revenue of SEK 2,357 million, missing the SEK 2.37 billion expected. The share price dropped about 15.87% after the figures, weighed down by currency headwinds that pushed absolute EBITA down to SEK 260 million. Positives include a 67% increase in operating cash flow; organic currency-adjusted growth was 3%, and the Medical Solutions segment grew organically by 5%. Management remains committed to strategic expansion plans and confirms the existing guidance despite short-term profitability pressures. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | September 2026 | YoY |
|---|---|---|
| Revenue | 220.51m | 4.79% |
| Gross profit | 40.22m | 7.35% |
| Net profit | 15.17m | 21.46% |
| EBITDA | 21.35m | 43.03% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €1.21bn |
Number of shares | 241.79m |
52-week high/low | €5.94 - €4.47 |
Dividend yield | 3.24% |
Dividends TTM | €0.16 |
Beta | 0.74 |
P/E ratio | 21.08 |
PEG ratio | -1.41 |
P/B ratio | 2.38 |
P/S ratio | 1.48 |
Company profile
Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products for medical technology, pharmaceutical, consumer electronics, telecom, automotive, and other industrial sectors in North America, Sweden, Asia, and other Europe region. The company offers consumables and reusable labware for clinical, chemical, forensic, research, and industrial testing laboratories; manufactures pipette tips, deep-well plates, microtubes, and PCR products; assemblies and post-processing services; and products for primary pharmaceutical packaging, as well as for solids, creams, and ophthalmic and customized production solutions. It designs, develops, and produces advanced components, subsystems, and ready-packaged electronics products, such as laser applications and ceramics, fitness trackers, loudspeaker systems, thermostats, webcams, and vaporiser heating products; automotive products; EMI shielding, thermal interface materials, and silicone sealing and damping solutions; and supplies plastic components and assemblies for food processing equipment, such as coffee machines and blenders. The company was formerly known as Nordiska Latexfabriken i Torekov AB and changed its name to Nolato AB (publ) in 1982. Nolato AB (publ) was incorporated in 1938 and is headquartered in Torekov, Sweden.
| Name | Nolato B |
| CEO | Anders Björklund |
| Headquarters | Torekov,
sn Sweden |
| Website | |
| IPO | 03/01/2000 |
| Employees | 5,607 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Sto | NOLA-B.ST |
Pnk | NLTBF |
Frankfurt | NBF.F |
Düsseldorf | NBF.DU |
London | 0OA9.L |
Stockholm | NOLA B.ST |
München | NBF.MU |